Skip to main content
. 2022 May 17;13:866325. doi: 10.3389/fphar.2022.866325

FIGURE 3.

FIGURE 3

Assessment of differences in prognosis, immune elements, and pathway enrichment between the two subtypes in TCGA cohort. (AC) Kaplan–Meier survival analysis of the two clusters in TCGA (OS, overall survival; EFS, event-free survival; RFS, relapse-free survival. C1 n = 82, C2 n = 68; log-rank p-test). (D,E) Comparison of the difference in immune cell fraction and immune response between the two subtypes, with CibersortX and ssGSEA algorithm (Wilcoxon tests). (F) FLT3-ITD, NPM1, and RUNX1 mutation distribution between the two subtypes (Chi-Square tests). (G,H) Heatmaps of GSVA-based KEGG and Hallmark analysis of the two subtypes (Wilcoxon tests).